Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

Well the way they’re spending money like water on all the PEGPH20 trials at the moment means they need a couple of new deals every year just to stave off more secondaries. If the 201 trial is a failure they should really rethink their whole PEG strategy. Enough is enough. The stock price could have been $100 by now if we hadn’t diluted endlessly on PEG for so far no reward whatsoever. HALO has been one of the worst performing big biotechs over the past decade because of their obsession to spend, spend, spend on PEG, Insulin, Hylenex, Cellulite etc. Hundreds of millions have been spent on these - if PEG fails on 201 let’s go back to basics on Enhanze and at least cut out these endless losses.